Recipharm, Moderna finalise agreement for COVID-19 vaccine outside US Recipharm to support formulation and fill-finish a part of Moderna COVID-19 vaccine supply in France facility
Gennova-HDT Biotech’s mRNA vaccine candidate gets DCGI nod for Phase 1 trials HGCO19 is stable at 2-8°C for two months and is supported by DBT, with seed grant under the Ind-CEPI mission
